EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Effect of Fenofibrate on Progression of Diabetic Retinopathy

David Preiss, Jennifer Logue, Emily Sammons, Mohammed Zayed, Jonathan Emberson, Rachel Wade, Karl Wallendszus, Will Stevens, Rosanna Cretney, Simon Harding, Graham Leese, Gemma Currie und 1 weitere

NEJM Evidence · 23.07.2024 · 3 (8)

DOI: 10.1056/evidoa2400179 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 23.07.2024. Verfasst von David Preiss und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Fenofibrate, Diabetic Retinopathy, Disease Progression, Hypolipidemic Agents. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FenofibrateDiabetic RetinopathyDisease ProgressionHypolipidemic AgentsHumansMaleFemaleMiddle AgedAgedAdultDouble-Blind Method

Substanzen

FenofibrateHypolipidemic Agents

Autor:innen und Institutionen

  • Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
  • Faculty of Health and Medicine, University of Lancaster, Lancaster, United Kingdom.
  • Department of Eye and Vision Science, University of Liverpool and St. Paul's Eye Unit, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.
  • Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
  • School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, United Kingdom.

Förderung

  • Department of Health

Zitieren

APA

Preiss, D., Logue, J., Sammons, E., Zayed, M., Emberson, J., Wade, R., Wallendszus, K., Stevens, W., Cretney, R., Harding, S., Leese, G., Currie, G., & Armitage, J. (2024). Effect of Fenofibrate on Progression of Diabetic Retinopathy. NEJM Evidence, 3(8). https://doi.org/10.1056/evidoa2400179

Vancouver

Preiss D, Logue J, Sammons E, Zayed M, Emberson J, Wade R, et al. Effect of Fenofibrate on Progression of Diabetic Retinopathy. NEJM Evidence. 2024;3(8). doi:10.1056/evidoa2400179

BibTeX
@article{Preiss2024,
  author = {Preiss, David and Logue, Jennifer and Sammons, Emily and Zayed, Mohammed and Emberson, Jonathan and Wade, Rachel and Wallendszus, Karl and Stevens, Will and Cretney, Rosanna and Harding, Simon and Leese, Graham and Currie, Gemma and Armitage, Jane},
  title = {Effect of Fenofibrate on Progression of Diabetic Retinopathy},
  journal = {NEJM Evidence},
  year = {2024},
  volume = {3},
  number = {8},
  doi = {10.1056/evidoa2400179}
}
Kostenlos starten →